This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Treating Excessive Daytime Sleepiness in Patients With Narcolepsy

Thomas Roth, PhD

Published: September 8, 2020

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders


Excessive daytime sleepiness (EDS) is a hallmark symptom of narcolepsy. The second major symptom, cataplexy, is present only in a subgroup of patients with narcolepsy. Fortunately, existing pharmacologic interventions are effective in reducing EDS for many patients, but elimination of EDS for most patients has not been achieved. Some interventions also show efficacy in cataplexy. Nonpharmacologic strategies should also be discussed with patients to provide optimal narcolepsy management. Clinicians must monitor EDS during ongoing treatment so that residual symptoms can be addressed with adjustment to the regimen. Research suggests a causative role for hypocretin deficiency in narcolepsy, and treatments ameliorating this deficiency are needed.

From the Series: Recognizing and Treating Excessive Daytime Sleepiness in Patients with Narcolepsy

To cite: Roth T. Treating EDS in patients with narcolepsy. J Clin Psychiatry. 2020;81(5):HB19045BR2C.
To share:
© Copyright 2020 Physicians Postgraduate Press, Inc.

Volume: 81

Quick Links: